These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16980034)

  • 41. Early short-term platelet-derived growth factor inhibition prevents the development of chronic allograft nephropathy in experimental rat kidney transplantation.
    Savikko J; Rintala J; von Willebrand E
    Transplant Proc; 2006 Dec; 38(10):3231-2. PubMed ID: 17175231
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
    Roos M; Liu S; Strobl M; Schmaderer C; Baumann M; Heemann U; Lutz J
    Transplant Proc; 2008 Dec; 40(10):3731-6. PubMed ID: 19100477
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distinct patterns of cytokine gene suppression by the equivalent effective doses of cyclosporine and tacrolimus in rat heart allografts.
    Jiang H; Yang X; Soriano RN; Fujimura T; Krishnan K; Kobayashi M
    Immunobiology; 2000 Sep; 202(3):280-92. PubMed ID: 11045663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term comparison of rat model of chronic allograft rejection of orthotopic small bowel transplantation induced by cyclosporine versus tacrolimus.
    Li Y; Zhu Y; Wang J; Wei W; Wu B; Li J
    Transplant Proc; 2013 Jun; 45(5):1811-5. PubMed ID: 23769050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].
    Qi Z; Yang DY; Wang R; Wang SZ; Ping YM
    Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):262-6. PubMed ID: 17502025
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protective effects of PG490-88 on chronic allograft rejection by changing intragraft gene expression profiles.
    Fisniku O; Pan F; Wynn C; Erickson LM; Crews G; Jang MS; Sudo Y; Tamura K; Kobayashi M; Benediktsson H; Jiang H
    Transplant Proc; 2005 May; 37(4):1962-4. PubMed ID: 15919518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapamycin: a bone sparing immunosuppressant?
    Romero DF; Buchinsky FJ; Rucinski B; Cvetkovic M; Bryer HP; Liang XG; Ma YF; Jee WS; Epstein S
    J Bone Miner Res; 1995 May; 10(5):760-8. PubMed ID: 7543725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conversion from cyclosporine to tacrolimus for chronic allograft nephropathy.
    Ji SM; Li LS; Sha GZ; Chen JS; Liu ZH
    Transplant Proc; 2007 Jun; 39(5):1402-5. PubMed ID: 17580148
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of rapamycin in experimental organ allografting.
    Ochiai T; Gunji Y; Nagata M; Komori A; Asano T; Isono K
    Transplantation; 1993 Jul; 56(1):15-9. PubMed ID: 8333037
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ischemic preconditioning improves rat kidney allograft function after ischemia/reperfusion injury: the role of tumor necrosis factor-alpha.
    Jia RP; Xie JJ; Luo FY; Zhu JG
    Transplant Proc; 2008 Dec; 40(10):3316-20. PubMed ID: 19100380
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TIRC7 is induced in rejected human kidneys and anti-TIRC7 mAb with FK506 prolongs survival of kidney allografts in rats.
    Kumamoto Y; Tamura A; Volk HD; Reinke P; Löhler J; Tullius SG; Utku N
    Transpl Immunol; 2006 Nov; 16(3-4):238-44. PubMed ID: 17138060
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effects of tacrolimus (FK506) on heat-shock proteins 70, Bcl-2 and Bax expression in nervous tissue of acrylamide-induced rat].
    Zhao S; Dou DD; Zeng T; Wang QS; Zhu ZP; Zhao XL; Xie KQ
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2010 Apr; 28(4):255-9. PubMed ID: 20465949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
    Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
    Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
    [TBL] [Abstract][Full Text] [Related]  

  • 56. All-trans retinoic acid attenuates cardiac allograft vasculopathy in rats.
    Zhang M; Wu Q; Shui C
    Transplant Proc; 2010 Jun; 42(5):1895-8. PubMed ID: 20620545
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Heme oxygenase-1 gene transfer protects rat kidney transplant from ischemia/reperfusion injury].
    Wu YD; Wang GX; Wei JX; Wen XG; Liu BQ; Wu CL; Han RF
    Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(18):1215-8. PubMed ID: 16271208
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Different effects of tacrolimus and cyclosporine on PDGF induction and chronic allograft injury: evidence for improved kidney graft outcome.
    Savikko J; Teppo AM; Taskinen E; von Willebrand E
    Transpl Immunol; 2014 Sep; 31(3):145-51. PubMed ID: 25158212
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of ligustrazine on chronic allograft nephropathy in rats.
    Gao C; Feng L; Li YP; Cheng Y
    Transplant Proc; 2007 Dec; 39(10):3415-9. PubMed ID: 18089395
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conversion from cyclosporine A to mycophenolate mofetil protects recipient kidney and prevents intimal hyperplasia in rat aortic allografts.
    Shimizu H; Takahashi M; Takeda S; Inoue S; Fujishiro J; Hakamata Y; Kaneko T; Murakami T; Takeyoshi I; Morishita Y; Kobayashi E
    Transpl Immunol; 2004 Nov; 13(3):219-27. PubMed ID: 15381205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.